Amgen is set to release its second-quarter earnings next month, and analysts are projecting modest single-digit growth in ...

Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of ...

Amgen Inc. closed 14.87% below its 52-week high of $346.85, which the company reached on July 25th.

Amgen combines patent protection, a robust pipeline, and strong execution for defensive investment. Click here to read an ...

Amgen Inc. closed 13.40% below its 52-week high of $346.85, which the company achieved on July 25th.

Amgen (AMGN) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

View the latest Amgen Inc. (AMG) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Amgen plans to proceed with Phase 3 trials, initiating patients on a lower dosage that will gradually increase over an eight-week period.

Amgen's long-acting experimental obesity drug MariTide needs to be given at a low starting dose to limit side effects like vomiting, according to mid-stage trial results presented at a medical meeting ...

Amgen said on Monday its experimental therapy helped patients with advanced gastric cancer live longer when combined with ...